A citation-based method for searching scientific literature

F Rozet, C Hennequin, J-B Beauval, P Beuzeboc, L Cormier, G Fromont-Hankard, P Mongiat-Artus, G Ploussard, R Mathieu, L Brureau, A Ouzzane, D Azria, I Brenot-Rossi, G Cancel-Tassin, O Cussenot, X Rebillard, T Lebret, M Soulié, R Renard Penna, A Méjean. Prog Urol 2018
Times Cited: 20







List of co-cited articles
68 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, Erik Briers, Marcus G Cumberbatch, Maria De Santis, Nicola Fossati, Tobias Gross, Ann M Henry, Steven Joniau,[...]. Eur Urol 2017
25

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
Freddie C Hamdy, Jenny L Donovan, J Athene Lane, Malcolm Mason, Chris Metcalfe, Peter Holding, Michael Davis, Tim J Peters, Emma L Turner, Richard M Martin,[...]. N Engl J Med 2016
20

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Nicholas D James, Matthew R Sydes, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Melissa R Spears, Alastair W S Ritchie, Christopher C Parker, J Martin Russell, Gerhardt Attard,[...]. Lancet 2016
864
15

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
Ian F Tannock, Ronald de Wit, William R Berry, Jozsef Horti, Anna Pluzanska, Kim N Chi, Stephane Oudard, Christine Théodore, Nicholas D James, Ingela Turesson,[...]. N Engl J Med 2004
15

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.
Jeffrey J Tosoian, Bruce J Trock, Patricia Landis, Zhaoyong Feng, Jonathan I Epstein, Alan W Partin, Patrick C Walsh, H Ballentine Carter. J Clin Oncol 2011
424
15

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Olivier Rouvière, Philippe Puech, Raphaële Renard-Penna, Michel Claudon, Catherine Roy, Florence Mège-Lechevallier, Myriam Decaussin-Petrucci, Marine Dubreuil-Chambardel, Laurent Magaud, Laurent Remontet,[...]. Lancet Oncol 2019
241
15

Prostate cancer treatment in renal transplant recipients: a systematic review.
Giancarlo Marra, Ettore Dalmasso, Marco Agnello, Stefania Munegato, Andrea Bosio, Omidreza Sedigh, Luigi Biancone, Paolo Gontero. BJU Int 2018
12
16

Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal Transplant Recipients.
J Iizuka, Yas Hashimoto, Yai Hashimoto, T Kondo, T Takagi, T Nozaki, T Shimizu, T Akimoto, H Ishida, K Karasawa,[...]. Transplant Proc 2016
7
28

Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients.
Marc Mouzin, Jean-Marc Bachaud, Nassim Kamar, Xavier Gamé, Christophe Vaessen, Pascal Rischmann, Lionel Rostaing, Bernard Malavaud. Transplantation 2004
45
10

Toxicity of radiotherapy in patients with collagen vascular disease.
Alexander Lin, Eyad Abu-Isa, Kent A Griffith, Edgar Ben-Josef. Cancer 2008
55
10

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
Daniel P Petrylak, Catherine M Tangen, Maha H A Hussain, Primo N Lara, Jeffrey A Jones, Mary Ellen Taplin, Patrick A Burch, Donna Berry, Carol Moinpour, Manish Kohli,[...]. N Engl J Med 2004
10

Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
Pierre Soubeyran, Carine Bellera, Jean Goyard, Damien Heitz, Hervé Curé, Hubert Rousselot, Gilles Albrand, Véronique Servent, Olivier Saint Jean, Isabelle van Praagh,[...]. PLoS One 2014
211
10

[Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].
Anne Cowppli-Bony, Marc Colonna, Karine Ligier, Valérie Jooste, Gautier Defossez, Alain Monnereau. Bull Cancer 2019
13
15

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
Christopher J Sweeney, Yu-Hui Chen, Michael Carducci, Glenn Liu, David F Jarrard, Mario Eisenberger, Yu-Ning Wong, Noah Hahn, Manish Kohli, Matthew M Cooney,[...]. N Engl J Med 2015
10

2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.
Pirkko-Liisa Kellokumpu-Lehtinen, Ulrika Harmenberg, Timo Joensuu, Ray McDermott, Petteri Hervonen, Claes Ginman, Marjaana Luukkaa, Paul Nyandoto, Akseli Hemminki, Sten Nilsson,[...]. Lancet Oncol 2013
91
10

Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
Anthony V D'Amico, Ming-Hui Chen, Andrew Renshaw, Marian Loffredo, Philip W Kantoff. JAMA 2015
73
10

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris A Hadaschik, Julie N Graff, David Olmos, Paul N Mainwaring, Ji Youl Lee, Hiroji Uemura,[...]. N Engl J Med 2018
435
10

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.
Abdenour Nabid, Nathalie Carrier, André-Guy Martin, Jean-Paul Bahary, Céline Lemaire, Sylvie Vass, Boris Bahoric, Robert Archambault, François Vincent, Redouane Bettahar,[...]. Eur Urol 2018
62
10


Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.
Seth A Rosenthal, Chen Hu, Oliver Sartor, Leonard G Gomella, Mahul B Amin, James Purdy, Jeff M Michalski, Mark G Garzotto, Nadeem Pervez, Alexander G Balogh,[...]. J Clin Oncol 2019
46
10

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.
Anders Widmark, Olbjørn Klepp, Arne Solberg, Jan-Erik Damber, Anders Angelsen, Per Fransson, Jo-Asmund Lund, Ilker Tasdemir, Morten Hoyer, Fredrik Wiklund,[...]. Lancet 2009
538
10

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).
Michel Bolla, Hein van Poppel, Bertrand Tombal, Kris Vekemans, Luigi Da Pozzo, Theo M de Reijke, Antony Verbaeys, Jean-François Bosset, Roland van Velthoven, Marc Colombel,[...]. Lancet 2012
507
10

Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial.
Nicolas Mottet, Michel Peneau, Jean-Jacques Mazeron, Vincent Molinie, Pierre Richaud. Eur Urol 2012
85
10

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
Almudena Zapatero, Araceli Guerrero, Xavier Maldonado, Ana Alvarez, Carmen Gonzalez San Segundo, Maria Angeles Cabeza Rodríguez, Victor Macias, Agustí Pedro Olive, Francesc Casas, Ana Boladeras,[...]. Lancet Oncol 2015
152
10

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
Padraig Warde, Malcolm Mason, Keyue Ding, Peter Kirkbride, Michael Brundage, Richard Cowan, Mary Gospodarowicz, Karen Sanders, Edmund Kostashuk, Greg Swanson,[...]. Lancet 2011
349
10

Enzalutamide in metastatic prostate cancer before chemotherapy.
Tomasz M Beer, Andrew J Armstrong, Dana E Rathkopf, Yohann Loriot, Cora N Sternberg, Celestia S Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury,[...]. N Engl J Med 2014
10

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.
Luca Incrocci, Ruud C Wortel, Wendimagegn Ghidey Alemayehu, Shafak Aluwini, Erik Schimmel, Stijn Krol, Peter-Paul van der Toorn, Hanja de Jager, Wilma Heemsbergen, Ben Heijmen,[...]. Lancet Oncol 2016
220
10

Radiotherapy and short-term androgen deprivation for localized prostate cancer.
Christopher U Jones, Daniel Hunt, David G McGowan, Mahul B Amin, Michael P Chetner, Deborah W Bruner, Mark H Leibenhaut, Siraj M Husain, Marvin Rotman, Luis Souhami,[...]. N Engl J Med 2011
398
10

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.
Ian M Thompson, Catherine M Tangen, Jorge Paradelo, M Scott Lucia, Gary Miller, Dean Troyer, Edward Messing, Jeffrey Forman, Joseph Chin, Gregory Swanson,[...]. J Urol 2009
814
10

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Nicholas D James, Johann S de Bono, Melissa R Spears, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Alastair W S Ritchie, Claire L Amos, Clare Gilson, Rob J Jones,[...]. N Engl J Med 2017
676
10

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
William U Shipley, Wendy Seiferheld, Himanshu R Lukka, Pierre P Major, Niall M Heney, David J Grignon, Oliver Sartor, Maltibehn P Patel, Jean-Paul Bahary, Anthony L Zietman,[...]. N Engl J Med 2017
273
10

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.
Michel Bolla, Philippe Maingon, Christian Carrie, Salvador Villa, Petros Kitsios, Philip M P Poortmans, Santhanam Sundar, Elzbieta M van der Steen-Banasik, John Armstrong, Jean-François Bosset,[...]. J Clin Oncol 2016
102
10

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke, Claudia Bronner, Ursula Steiner, Alessandra Siegmann, Reinhard Golz, Stephan Störkel, Normann Willich, Axel Semjonow,[...]. Eur Urol 2014
218
10

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Karim Fizazi, Laura Faivre, François Lesaunier, Remy Delva, Gwenaëlle Gravis, Frédéric Rolland, Frank Priou, Jean-Marc Ferrero, Nadine Houede, Loïc Mourey,[...]. Lancet Oncol 2015
134
10

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Christian Carrie, Ali Hasbini, Guy de Laroche, Pierre Richaud, Stéphane Guerif, Igor Latorzeff, Stéphane Supiot, Mathieu Bosset, Jean-Léon Lagrange, Véronique Beckendorf,[...]. Lancet Oncol 2016
204
10

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.
Claire L Vale, Sarah Burdett, Larysa H M Rydzewska, Laurence Albiges, Noel W Clarke, David Fisher, Karim Fizazi, Gwenaelle Gravis, Nicholas D James, Malcolm D Mason,[...]. Lancet Oncol 2016
234
10

[French ccAFU guidelines - Update 2018-2020: Upper tract urothelial carcinoma].
M Rouprêt, E Xylinas, P Colin, N Houédé, E Compérat, F Audenet, S Larré, A Masson-Lecomte, G Pignot, S Brunelle,[...]. Prog Urol 2018
3
66

Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).
Timothy J Wilt, Tien N Vo, Lisa Langsetmo, Philipp Dahm, Thomas Wheeler, William J Aronson, Matthew R Cooperberg, Brent C Taylor, Michael K Brawer. Eur Urol 2020
22
10

Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.
Grace L Lu-Yao, Peter C Albertsen, Dirk F Moore, Yong Lin, Robert S DiPaola, Siu-Long Yao. Eur Urol 2015
37
10

Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.
Hima Bindu Musunuru, Toshihiro Yamamoto, Laurence Klotz, Gabriella Ghanem, Alexandre Mamedov, Peraka Sethukavalan, Vibhuti Jethava, Suneil Jain, Liying Zhang, Danny Vesprini,[...]. J Urol 2016
92
10

Medium-term outcomes of active surveillance for localised prostate cancer.
Elizabeth D Selvadurai, Mausam Singhera, Karen Thomas, Kabir Mohammed, Ruth Woode-Amissah, Alan Horwich, Robert A Huddart, David P Dearnaley, Chris C Parker. Eur Urol 2013
142
10

Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.
Laurence Klotz, Danny Vesprini, Perakaa Sethukavalan, Vibhuti Jethava, Liying Zhang, Suneil Jain, Toshihiro Yamamoto, Alexandre Mamedov, Andrew Loblaw. J Clin Oncol 2015
626
10

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.
Jeffrey J Tosoian, Mufaddal Mamawala, Jonathan I Epstein, Patricia Landis, Katarzyna J Macura, Demetrios N Simopoulos, H Ballentine Carter, Michael A Gorin. Eur Urol 2020
33
10

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.
Meelan Bul, Xiaoye Zhu, Riccardo Valdagni, Tom Pickles, Yoshiyuki Kakehi, Antti Rannikko, Anders Bjartell, Deric K van der Schoot, Erik B Cornel, Giario N Conti,[...]. Eur Urol 2013
321
10

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
J L Donovan, F C Hamdy, J A Lane, M Mason, C Metcalfe, E Walsh, J M Blazeby, T J Peters, P Holding, S Bonnington,[...]. N Engl J Med 2016
515
10

Radical prostatectomy versus observation for localized prostate cancer.
Timothy J Wilt, Michael K Brawer, Karen M Jones, Michael J Barry, William J Aronson, Steven Fox, Jeffrey R Gingrich, John T Wei, Patricia Gilhooly, B Mayer Grob,[...]. N Engl J Med 2012
10

Chlordecone exposure and risk of prostate cancer.
Luc Multigner, Jean Rodrigue Ndong, Arnaud Giusti, Marc Romana, Helene Delacroix-Maillard, Sylvaine Cordier, Bernard Jégou, Jean Pierre Thome, Pascal Blanchet. J Clin Oncol 2010
159
10

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.
Ethan Basch, Allison M Deal, Amylou C Dueck, Howard I Scher, Mark G Kris, Clifford Hudis, Deborah Schrag. JAMA 2017
614
10


Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study.
Caroline Pettenati, Anne-Sophie Jannot, Sophie Hurel, Virginie Verkarre, Henri Kreis, Martin Housset, Christophe Legendre, Arnaud Méjean, Marc-Olivier Timsit. Clin Transplant 2016
19
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.